Hepatic Cell News Volume 5.20 | June 4 2021

    0
    30






    Subject


    Hepatic Cell News by STEMCELL Technologies
    Vol. 5.20 – 4 June, 2021
    TOP STORY

    Hepatic
    Stellate Cells Suppress NK Cell-Sustained Breast Cancer Dormancy

    The proteomics studies on liver co-cultures implicated the activated hepatic stellate cells-secreted chemokine CXCL12 in the induction of natural killer (NK) cell quiescence through its cognate receptor CXCR4.
    [Nature]

    Abstract


    Request your free copy of the 'Directed Differentiation of Pluripotent Stem Cells' Wallchart
    PUBLICATIONSRanked by the impact factor of the journal

    Lenvatinib Targets FGFR4 to Enhance Antitumor Immune Response of Anti-PD-1 in Hepatocellular Carcinoma

    Scientists showed that fibroblast growth factor receptor 4 (FGFR4) was the most pivotal target in programmed death ligand 1 down-regulation by lenvatinib in vitro.
    [Hepatology]

    Abstract


    Nuclear Scaffold Protein p54nrb/NONO Facilitates the Hypoxia-Enhanced Progression of Hepatocellular Carcinoma

    Researchers found multifunction scaffold protein p54nrb/NONO exerted pleiotropic effects to regulate hypoxia transcription signals, thereby enhancing the progression of liver cancer.
    [Oncogene]

    Full Article

    Pterostilbene Improves Insulin Resistance Caused by Advanced Glycation End Products (AGEs) in Hepatocytes and Mice

    Scientists investigated if pterostilbene regulated glucose metabolism and insulin signaling, as well as its potential mechanism in the context of AGEs exposure.
    [Molecular Nutrition & Food Research]

    Abstract

    The Expression Profiles and Prognostic Values of HSP70s in Hepatocellular Carcinoma

    Cell experiments have confirmed that reducing HSPA4 and HSPA14 expressions could inhibit the invasion, metastasis, and proliferation of hepatocellular carcinoma cells.
    [Cancer Cell International]

    Full Article


    Synergistic Effect of Toosendanin and Regorafenib against Cell Proliferation and Migration by Regulating WWOX Signaling Pathway in Hepatocellular Carcinoma

    Scientists identified that TSN and RGF combination synergistically inhibited the proliferation and migration of MHCC-97L cells.
    [Phytotherapy Research]

    Abstract


    Transformation of SOX9+ Cells by Pten Deletion Synergizes with Steatotic Liver Injury to Drive Development of Hepatocellular and Cholangiocarcinoma

    Researchers employed lineage-tracing to demonstrate the tumorigenicity potential of the Pten, SOX9+ cells. They showed that these cells were capable of giving rise to mixed-lineage tumors that manifested features of both hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
    [Scientific Reports]

    Full Article

    A
    Novel, Multitargeted Endogenous Metabolic Modulator Composition Impacts Metabolism, Inflammation, and Fibrosis in Nonalcoholic Steatohepatitis-Relevant Primary Human Cell Models

    Investigators described a study of a novel endogenous metabolic modulators composition comprising five amino acids and an amino acid derivative and its systematic evaluation across multiple nonalcoholic steatohepatitis-relevant primary human cell model systems, including hepatocytes, macrophages, and stellate cells.
    [Scientific Reports]

    Full Article

    Manuka Honey Enhanced Sensitivity of HepG2, Hepatocellular Carcinoma Cells, for Doxorubicin and Induced Apoptosis through Inhibition of Wnt/β-Catenin and ERK1/2

    Scientists investigated the molecular mechanism and synergistic effect of anticancer properties of MH on Doxorubicin-mediated apoptotic cell death, using two different p53 statuses and one non-tumorigenic immortalized liver cell line.
    [Biological Research]

    Full Article

    Download an e-book covering the evolution of organoids, from their development to updated applications and future outlooks.
    REVIEWS

    The Microbiota in Cirrhosis and Its Role in Hepatic Decompensation

    This review focuses on the role of microbiota in decompensation and strategies targeting microbiota to prevent acute decompensation.
    [Journal of Hepatology]

    Full Article


    Liver Regeneration and Inflammation: From Fundamental Science to Clinical Applications

    The authors describe the mechanisms of tissue repair following damage, highlighting the close relationship between inflammation and liver regeneration, and discuss how recent findings can help design novel therapeutic approaches.
    [Nature Reviews Molecular Cell Biology]

    Abstract

    INDUSTRY AND POLICY NEWS

    Boehringer Ingelheim and Zealand Pharma Receive FDA Fast Track Designation for Investigational Treatment for NASH

    Boehringer Ingelheim and Zealand Pharma announced that the US FDA has granted Fast Track Designation to the GLP-1/glucagon dual agonist BI 456906 for adults with non-alcoholic steatohepatitis (NASH).
    [Boehringer Ingelheim, Inc. (Globenews Wire, Inc.]

    Press Release

    Can-Fite to Initiate Phase IIb NASH Study with Its Drug Candidate Namodenoson

    Can-Fite BioPharma Ltd. announced that it has received clearance from the Israeli Ministry of Health to commence a Phase IIb study of its drug candidate Namodenoson in the treatment of non-alcoholic steatohepatitis (NASH).
    [Can-Fite BioPharma Ltd.]

    Press Release

    FEATURED EVENT

    World
    Stem Cell Summit

    June 14 – 18, 2021
    Virtual


    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Fellow – Gut-Liver Microbiome

    Oslo University Hospital – Oslo, Norway

    Bioinformatician – Genomics

    Deep Genomics, Inc. – Toronto, Ontario, Canada

    Assistant Professor – Drug Metabolism, Liver Disease

    University of Pittsburgh – Pittsburgh, Pennsylvania, United States

    Director – Liver Disease

    The Griffin Institute – Harrow, United Kingdom

    Senior Associate Scientist – Fibrosis Biology

    Gilead Sciences, Inc. – Foster City, California, United States


    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Hepatic Cell News Twitter